Researchers from INCLIVA developed a blood-based test, TAV16, to detect micrometastases in early-stage colon cancer with unprecedented sensitivity. Using ctDNA analysis, it predicts relapse risk more...
With the first part of their project completed and the good results endorsing Ikan Biotech, the next step that both Rubén and Roberto considered was to...